OVERWEIGHT OR OBESITY
Clinical trials for OVERWEIGHT OR OBESITY explained in plain language.
Never miss a new study
Get alerted when new OVERWEIGHT OR OBESITY trials appear
Sign up with your email to follow new studies for OVERWEIGHT OR OBESITY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New monthly shot aims to help people lose weight
Disease control OngoingThis study is testing whether a new drug called MET097, given as a monthly injection after initial weekly doses, helps people with obesity or overweight lose weight. About 250 adults will receive either the drug or a placebo (inactive shot) for over a year to see which is more ef…
Matched conditions: OVERWEIGHT OR OBESITY
Phase: PHASE2 • Sponsor: Metsera, a wholly owned subsidiary of Pfizer • Aim: Disease control
Last updated Apr 01, 2026 22:41 UTC
-
First human tests begin for experimental obesity medication
Disease control OngoingThis early-stage study is testing the safety and side effects of a new weight management drug called IBI3032 in people who are overweight or have obesity. The trial involves 79 participants who will receive either the drug or a placebo over 4 weeks. Researchers are primarily chec…
Matched conditions: OVERWEIGHT OR OBESITY
Phase: PHASE1 • Sponsor: Innovent Biologics Technology Limited (Shanghai R&D Center) • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New pill aims to tame sleep apnea and shed pounds
Disease control OngoingThis study is testing a once-daily pill called orforglipron to see if it can reduce breathing pauses during sleep (sleep apnea) and help with weight loss in adults who are overweight or have obesity. It will involve about 600 people, including those who do and do not use a standa…
Matched conditions: OVERWEIGHT OR OBESITY
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Weekly shot aims to shrink waistlines in major obesity trial
Disease control OngoingThis study is testing whether a new weekly injection called MET097 helps people with obesity or overweight lose weight compared to a placebo shot. About 225 adults will receive either the drug or a placebo for 28 weeks to see which group loses more weight and has fewer side effec…
Matched conditions: OVERWEIGHT OR OBESITY
Phase: PHASE2 • Sponsor: Metsera, a wholly owned subsidiary of Pfizer • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
New daily pill aims to help millions shed pounds and improve health
Disease control OngoingThis large, late-stage study is testing whether a once-daily oral medication called orforglipron can help adults with obesity or overweight lose weight and improve related health conditions like high blood pressure or cholesterol. Over 3,100 participants will take the drug or a p…
Matched conditions: OVERWEIGHT OR OBESITY
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC
-
Diabetes game changer? pill vs. insulin in major heart safety trial
Disease control OngoingThis large, late-stage study is testing whether a new once-daily pill called orforglipron is as safe and effective as standard insulin injections for adults with type 2 diabetes who also have obesity or are overweight and are at higher risk for heart problems. It will involve abo…
Matched conditions: OVERWEIGHT OR OBESITY
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC
-
Can diet beat pills for fixing a fatty liver?
Disease control ENROLLING_BY_INVITATIONThis study aims to see if a specific eating plan is better than a prescription medication for reducing liver fat and scarring. Researchers will compare a Mediterranean diet combined with intermittent fasting against the weight-loss drug naltrexone/bupropion (Mysimba®). The goal i…
Matched conditions: OVERWEIGHT OR OBESITY
Phase: PHASE4 • Sponsor: Carmen Dietvorst • Aim: Disease control
Last updated Mar 10, 2026 12:53 UTC
-
Breathing treatment may stop diabetes before it starts
Prevention OngoingThis study is testing whether adding a CPAP breathing machine to a standard diet and exercise program can better prevent diabetes in overweight adults with prediabetes and sleep apnea. Researchers want to see if treating sleep apnea improves blood sugar and heart health more than…
Matched conditions: OVERWEIGHT OR OBESITY
Phase: NA • Sponsor: University of Chicago • Aim: Prevention
Last updated Mar 27, 2026 12:39 UTC
-
Scientists probe Liver's inner workings to predict surgery success
Knowledge-focused OngoingThis study aims to understand how the liver's energy production changes in people with fatty liver disease (NASH) who are undergoing weight loss surgery. Researchers will measure how the liver burns fat and makes sugar in 30 participants before their surgery. The goal is to see i…
Matched conditions: OVERWEIGHT OR OBESITY
Phase: NA • Sponsor: University of Minnesota • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:35 UTC
-
Scientists build a 'Library' of samples to unlock Obesity's secrets
Knowledge-focused OngoingThis study aims to collect and store biological samples from 500 people with obesity. The goal is to build a repository of blood, urine, and tissue to help researchers understand why weight loss treatments sometimes work or fail, and why weight is often regained. This is an obser…
Matched conditions: OVERWEIGHT OR OBESITY
Sponsor: Pichamol Jirapinyo, MD, MPH • Aim: Knowledge-focused
Last updated Mar 25, 2026 14:08 UTC
-
Gut health secrets in Low-Carb diet revealed!
TerminatedThis study aimed to see how gut bacteria and blood chemicals change in overweight or obese adults following a special low-carb diet. Participants would provide stool and blood samples as they lost weight. The goal was to understand how diet affects gut health during weight loss.
Matched conditions: OVERWEIGHT OR OBESITY
Sponsor: Westlake University
Last updated Nov 25, 2025 13:45 UTC